top of page

Welcome to the first Nordic Psychedelic Science Conference in Oslo May 19th & 20th

Why a psychedelic science conference?

The science of psychedelics is rapidly expanding

Nordic researchers are currently participating in international trials using MDMA, psilocybin and ketamine and psychedelics are increasingly prominent in the fields of basic science and social science.

We believe that the time has come to put the Nordic countries on the map of global psychedelic research and building a foundation for an organized scientific field is the next step in achieving that goal. 


Join the frontier

Nordic Psychedelic Science Conference (NPSC) is a conference dedicated to the field of psychedelic research within the Nordic countries. Participants will get the chance to be updated on the latest research, discover what opportunities might exist in the future and get to meet the experts within the field. 

What is psychedelic science?

Psychedelic Science refers to a field of scientific research focused on the substances commonly classified as psychedelics.


Classical psychedelics are lysergic acid diethylamide (LSD), psilocybin, N,N-Dimethyltryptamine (DMT) and mescaline. Although not regarded as classical psychedelics, substances such as ketamine and methylenedioxymethamphetamine (MDMA) are often included in a broader definition. Psychedelics are also sometimes referred to as hallucinogens or entheogens.


The commonality of these substances is referred to in the word psychedelic itself, which from its Greek origin translates to “mind manifesting” (psychē dēloun). The ability of these substances to enhance perception of meaning, produce mystical experiences and an altered perception of self is what gives these substances their own characteristics. These characteristics are also what makes psychedelics an interesting field of study across a variety of academic disciplines.  


To learn more about psychedelic science check out

How is psychedelic science relevant?

Psychedelic science is most often tied to the field of medicine. Classical psychedelics have yet to be approved for treatment, however, preliminary data suggests that psychedelic-assisted therapies may be effective for some of our most prevalent and debilitating conditions such as treatment resistant depression and drug addiction. If ongoing research continues to show efficacy, there may be a public health imperative to advance our understanding and application of these treatments. 


However, psychedelic science is not limited to mental health. Psychedelic substances produce unusual and compelling changes in conscious experience that have prompted some to propose that psychedelics may provide unique insights explaining the nature of consciousness which involve relations between subjectivity, brain function, and behavior. 


Within neuroscience there are studies looking into the mechanisms of psychedelics in the brain using brain mapping technologies such as PET and MRI. Studies suggest that psychedelics may facilitate neuroplasticity at the cellular and network levels allowing the brain to form and reorganize connections. Within immunology scientists are looking into the potential of psychedelics to modulate immune functions which might lead to treatments of inflammatory and immune-related diseases.


Social science has studied indigenous use of psychedelics for a long time because psilocybin, DMT, mescaline, as well as Ibogaine, can be found naturally occurring in nature. Communities all over the world have been documented using psychedelic plants and mushrooms as a religious sacrament or plant medicine. In recent years there has also been a growing number of social scientists looking into the recreational use of psychedelics in modern societies, shedding light on the cultural significance of these substances.

The organizers

Nordic Psychedelic Science Conference is hosted by the association Norwegian Psychedelic Science (NPV). NPV is a non-profit organization run by academics and researchers within the field of psychedelic science in Norway.

Our mission is to enhance scientific inquiry into psychedelic substances and their clinical potential as well as create a network of healthcare workers, academics and scientists interested in psychedelic science. Learn more about us at

The conference is hosted in partnership with the research team PsykForsk at Sykehuset Østfold and our associated organizations in Sweden and Denmark.

bottom of page